The CVD-1 High Cholesterol Testing panel is an essential set of screenings designed to evaluate cardiovascular health and risk factors associated with heart disease. This panel includes tests for high-sensitivity C-Reactive Protein (hs-CRP) and a comprehensive Lipid Panel with Ratios. It serves as a foundational tool for identifying individuals at risk for cardiovascular disease (CVD), particularly those related to cholesterol levels and inflammation, which are significant contributors to heart disease.

 The CVD-2 High Cholesterol Testing panel is an advanced diagnostic tool designed to provide a comprehensive assessment of cardiovascular health and risks associated with cholesterol levels and other significant markers. This panel includes tests for Apolipoprotein A1, Apolipoprotein B, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, and VLDL Cholesterol. This panel is designed for individuals at risk of cardiovascular disease, providing a deeper insight into lipid profiles and inflammatory markers.

 The CVD-3 High Cholesterol Testing panel is a thorough diagnostic tool aimed at evaluating cardiovascular health by examining a broad spectrum of lipid profiles, inflammatory markers, and other specific tests related to heart disease risk. This panel includes Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol. It's designed for a comprehensive assessment of cardiovascular risk factors, particularly for individuals at high risk or with existing cardiovascular conditions.

 The CVD-4 High Cholesterol Testing panel represents the most comprehensive assessment in the series of cardiovascular diagnostics. It is designed to provide an extensive evaluation of cardiovascular risk factors, including genetic predispositions, lipid profiles, inflammatory markers, and more. This panel includes the Cardio IQ™ ApoE Genotype, Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol.

The Apolipoprotein A1 (Apo A1) Test measures levels of Apo A1, the main protein in HDL cholesterol, to assess heart and vascular health. Higher levels are linked to protective “good” cholesterol, while low levels may increase risk of heart disease, stroke, or metabolic disorders. Doctors use this test with lipid panels to evaluate cardiovascular risk, monitor therapy, and guide prevention strategies for cholesterol balance and heart health.

The Lp-PLA2 Activity Test measures lipoprotein-associated phospholipase A2 enzyme activity, a marker of vascular inflammation linked to atherosclerosis and cardiovascular disease. Elevated levels may increase risk for heart attack and stroke. Doctors order this test for patients with high cholesterol, metabolic syndrome, or other risk factors. Results provide valuable insight into arterial health, helping guide prevention, treatment, and heart disease management.

The Cardio IQ™ Lp-PLA2 PLAC® Test measures lipoprotein-associated phospholipase A2, an enzyme linked to vascular inflammation and plaque instability. Elevated levels are associated with increased risk of coronary heart disease and ischemic stroke. Doctors use this blood test to assess cardiovascular risk beyond standard cholesterol testing, helping guide prevention and treatment strategies to reduce risk of heart attack or stroke.

The Cardio IQ™ hs-CRP Test measures high-sensitivity C-reactive protein in the blood to assess inflammation linked to cardiovascular risk. Elevated levels may indicate a higher risk of heart disease or other inflammatory conditions.

The Cardio IQ™ Lipid Panel is a test that assesses a patient's risk of cardiovascular disease (CVD) by examining total cholesterol, LDL, HDL, and triglycerides.

The Cardio IQ™ Homocysteine Test measures homocysteine levels in the blood, an amino acid linked to cardiovascular risk. Elevated levels may indicate increased risk for heart disease, stroke, or vitamin deficiencies (B6, B12, folate). This test helps assess cardiovascular health and guide prevention strategies.

The Cardio IQ™ Apolipoprotein A1 Test measures ApoA1, the main protein in HDL cholesterol. Higher ApoA1 levels are generally linked to lower cardiovascular risk. This test helps evaluate heart health, lipid metabolism, and supports assessment of cardiovascular disease risk.